Published in Prostaglandins Leukot Essent Fatty Acids on July 07, 2006
Routes to 4-hydroxynonenal: fundamental issues in the mechanisms of lipid peroxidation. J Biol Chem (2008) 1.76
RLIP76 in defense of radiation poisoning. Int J Radiat Oncol Biol Phys (2008) 1.10
Dietary oxidized n-3 PUFA induce oxidative stress and inflammation: role of intestinal absorption of 4-HHE and reactivity in intestinal cells. J Lipid Res (2012) 0.98
Detoxification reactions: relevance to aging. Ageing Res Rev (2008) 0.98
Role of lipid peroxidation derived 4-hydroxynonenal (4-HNE) in cancer: focusing on mitochondria. Redox Biol (2014) 0.94
Fat accumulation in Caenorhabditis elegans triggered by the electrophilic lipid peroxidation product 4-hydroxynonenal (4-HNE). Aging (Albany NY) (2008) 0.93
Ozone acting on human blood yields a hormetic dose-response relationship. J Transl Med (2011) 0.90
Hydroxyalkenals and oxidized phospholipids modulation of endothelial cytoskeleton, focal adhesion and adherens junction proteins in regulating endothelial barrier function. Microvasc Res (2011) 0.88
Obesity in a model of gpx4 haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy. Mol Metab (2015) 0.82
Dietary carnosine prevents early atherosclerotic lesion formation in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol (2013) 0.82
Effects of 6 weeks of n-3 fatty acids and antioxidant mixture on lipid peroxidation at rest and postexercise. Eur J Appl Physiol (2011) 0.78
LC-MS/MS quantitation of mercapturic acid conjugates of lipid peroxidation products as markers of oxidative stress. Curr Protoc Toxicol (2011) 0.76
Fish oil, lard and soybean oil differentially shape gut microbiota of middle-aged rats. Sci Rep (2017) 0.75
Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins. Toxins (Basel) (2016) 0.75
Shotgun lipidomics in substantiating lipid peroxidation in redox biology: Methods and applications. Redox Biol (2017) 0.75
The Role of Omega-3 Polyunsaturated Fatty Acids in Stroke. Oxid Med Cell Longev (2016) 0.75
Policy interventions that attract nurses to rural areas: a multicountry discrete choice experiment. Bull World Health Organ (2010) 2.17
Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem J (2000) 1.89
Fatty acid substrate specificities of human prostaglandin-endoperoxide H synthase-1 and -2. Formation of 12-hydroxy-(9Z, 13E/Z, 15Z)- octadecatrienoic acids from alpha-linolenic acid. J Biol Chem (1995) 1.45
A simple and efficient method for platelet isolation from their plasma. Thromb Res (1980) 1.26
Requirement and role of arachidonic acid in the differentiation of pre-adipose cells. Biochem J (1989) 1.25
Blood compartmental metabolism of docosahexaenoic acid (DHA) in humans after ingestion of a single dose of [(13)C]DHA in phosphatidylcholine. J Lipid Res (1999) 1.15
Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes. Free Radic Biol Med (2005) 1.15
The phospholipid and fatty acid composition of human platelet surface and intracellular membranes isolated by high voltage free flow electrophoresis. J Biol Chem (1982) 1.12
13-Hydroxyoctadecadienoic acid is the vessel wall chemorepellant factor, LOX. J Biol Chem (1985) 1.11
Retroconversion and metabolism of [13C]22:6n-3 in humans and rats after intake of a single dose of [13C]22:6n-3-triacylglycerols. Am J Clin Nutr (1996) 1.09
Localisation of phospholipase A2 and diglyceride lipase activities in human platelet intracellular membranes. FEBS Lett (1981) 1.08
Preferential incorporation of sn-2 lysoPC DHA over unesterified DHA in the young rat brain. Am J Physiol (1994) 1.06
Covalent modifications of aminophospholipids by 4-hydroxynonenal. Free Radic Biol Med (1998) 1.05
Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation. Biochem Pharmacol (1999) 1.05
Human plasma albumin transports [13C]docosahexaenoic acid in two lipid forms to blood cells. J Lipid Res (1997) 1.04
The cAMP-specific phosphodiesterase PDE4D3 is regulated by phosphatidic acid binding. Consequences for cAMP signaling pathway and characterization of a phosphatidic acid binding site. J Biol Chem (2000) 1.04
Unsaturated fatty acids esterified in 2-acyl-l-lysophosphatidylcholine bound to albumin are more efficiently taken up by the young rat brain than the unesterified form. J Neurochem (1992) 1.03
Platelets mediate the action of diethylcarbamazine on microfilariae. Nature (1987) 1.02
Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina. Arch Biochem Biophys (1999) 1.01
Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation. FEBS Lett (2009) 1.01
Increase of platelet thromboxane A2 formation and of its plasmatic half-life in diabetes mellitus. Thromb Res (1980) 0.99
Covalent binding of 15-deoxy-delta12,14-prostaglandin J2 to PPARgamma. Biochem Biophys Res Commun (2005) 0.98
Phosphodiesterase inhibitory profile of some related xanthine derivatives pharmacologically active on the peripheral microcirculation. Biochem Pharmacol (1994) 0.95
Thrombocytopenia, macrothrombocytopathia, nephritis and deafness. Am J Med (1976) 0.95
The lipid peroxidation end-product 4-HNE induces COX-2 expression through p38MAPK activation in 3T3-L1 adipose cell. FEBS Lett (2007) 0.95
Modification of enzymatic antioxidants in retinal microvascular cells by glucose or advanced glycation end products. Free Radic Biol Med (1998) 0.92
Protective effect of docosahexaenoic acid against hydrogen peroxide-induced oxidative stress in human lymphocytes. Biochem Pharmacol (1999) 0.91
Stereospecific inhibition of PGH2-induced platelet aggregation by lipoxygenase products of icosaenoic acids. Biochem Biophys Res Commun (1983) 0.91
12-HETE inhibits the binding of PGH2/TXA2 receptor ligands in human platelets. Thromb Res (1991) 0.90
Docosahexaenoic acid is a major n-3 polyunsaturated fatty acid in bovine retinal microvessels. J Neurochem (1996) 0.90
Metabolic fate of an oral tracer dose of [13C]docosahexaenoic acid triglycerides in the rat. Am J Physiol (1996) 0.89
LDL from obese patients with the metabolic syndrome show increased lipid peroxidation and activate platelets. Diabetologia (2011) 0.89
Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid. Thromb Res (1984) 0.89
Role of lipoxygenase products in platelet function: relation to fatty acid modified phospholipids. Adv Exp Med Biol (1985) 0.88
Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents. Mol Pharmacol (1993) 0.88
Aldehydes from n-6 fatty acid peroxidation. Effects on aminophospholipids. Prostaglandins Leukot Essent Fatty Acids (2002) 0.87
Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes. J Mol Cell Cardiol (1996) 0.87
Mitochondrial H2O2 production is reduced with acute and chronic eccentric exercise in rat skeletal muscle. Antioxid Redox Signal (2006) 0.87
Stable isotope tracer and gas-chromatography combustion isotope ratio mass spectrometry to study the in vivo compartmental metabolism of docosahexaenoic acid. Anal Biochem (1994) 0.87
Platelets and aging. I--Aggregation, arachidonate metabolism and antioxidant status. Thromb Res (1988) 0.86
Interactions between prostaglandin precursors during their oxygenation by human platelets. Biochim Biophys Acta (1982) 0.86
Involvement of cell-cell interactions in the pathogenesis of diabetic retinopathy. Diabetes Metab (1997) 0.86
Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother (2013) 0.86
Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo-oxygenase activation. Biochem J (1997) 0.86
Involvement of type 4 cAMP-phosphodiesterase in the myogenic differentiation of L6 cells. Mol Biol Cell (1999) 0.86
The influence of low intake of n-3 fatty acids on platelets in elderly people. Atherosclerosis (1999) 0.86
DHA metabolism: targeting the brain and lipoxygenation. Mol Neurobiol (2010) 0.86
Functional lipidomics of oxidized products from polyunsaturated fatty acids. Chem Phys Lipids (2011) 0.86
Gas chromatographic-mass spectrometric measurement of 15-deoxy-delta(12,14)-prostaglandin J(2), the peroxisome proliferator-activated receptor gamma ligand, in urine. Clin Chem (2001) 0.86
Preferential transfer of 2-docosahexaenoyl-1-lysophosphatidylcholine through an in vitro blood-brain barrier over unesterified docosahexaenoic acid. J Neurochem (1999) 0.86
Effect of glycated LDL on microvascular tone in mice: a comparative study with LDL modified in vitro or isolated from diabetic patients. Diabetologia (2003) 0.85
Specific markers of lipid peroxidation issued from n-3 and n-6 fatty acids. Biochem Soc Trans (2004) 0.85
In vitro incorporation and metabolism of icosapentaenoic and docosahexaenoic acids in human platelets--effect on aggregation. Thromb Haemost (1986) 0.85
Diacylglycerol lipase activity in human platelet intracellular and surface membranes. Some kinetic properties and fatty acid specificity. FEBS Lett (1985) 0.85
Leukotriene B4 level in stimulated blood neutrophils and alveolar macrophages from healthy and asthmatic subjects. Effect of beta-2 agonist therapy. Eur J Clin Invest (1992) 0.85
Hyperglycaemia modifies the reaction of microvessels to insulin in rat skeletal muscle. Diabetologia (1998) 0.84
Early increase in lymphocyte cyclic nucleotide phosphodiesterase activity upon mitogenic activation of human peripheral blood mononuclear cells. J Cell Physiol (1992) 0.84
Phosphatidic acid stimulates the rolipram-sensitive cyclic nucleotide phosphodiesterase from rat thymocytes. Biochim Biophys Acta (1993) 0.84
Albumin antioxidant capacity is modified by methylglyoxal. Diabetes Metab (2005) 0.84
Antibiotics and production of granulocyte-macrophage colony-stimulating factor by human bronchial epithelial cells in vitro. A comparison of cefodizime and ceftriaxone. Arzneimittelforschung (1994) 0.84
Effects of fatty acids on human platelet glutathione peroxidase: possible role of oxidative stress. Biochem Pharmacol (1997) 0.84
The impaired in vitro production of interleukin-2 in HIV infection is negatively correlated to the number of circulating CD4+DR+ T cells and is reversed by allowing T cells to rest in culture: arguments for in vivo CD4+ T cell activation. Clin Immunol Immunopathol (1993) 0.83
Lipoxygenase activity of intact human platelets. Prostaglandins Leukot Med (1984) 0.83
12(S)-Hydroperoxy-eicosatetraenoic acid increases arachidonic acid availability in collagen-primed platelets. J Lipid Res (2001) 0.83
Selective stimulation of a cAMP-specific phosphodiesterase (PDE4A5) isoform by phosphatidic acid molecular species endogenously formed in rat thymocytes. Eur J Biochem (1997) 0.83
Docosapentaenoic acid (22:5,n-3): metabolism and effect on prostacyclin production in endothelial cells. Prostaglandins Leukot Essent Fatty Acids (1996) 0.82
Incorporation and turnover of eicosapentaenoic and docosahexaenoic acids in human blood platelets in vitro. Biochem J (1992) 0.82
Age-related changes in arachidonic acid peroxidation and glutathione-peroxidase activity in human platelets. Prostaglandins (1992) 0.82
Human lymphocytes stimulate prostacyclin synthesis in human umbilical vein endothelial cells. Involvement of endothelial cPLA2. J Leukoc Biol (2000) 0.82
Inhibition of the different phosphodiesterase isoforms of rat heart cytosol by free fatty acids. J Cardiovasc Pharmacol (1993) 0.82
Age-related changes in antioxidant defence mechanisms and peroxidation in isolated hepatocytes from spontaneously hypertensive and normotensive rats. Mol Cell Biochem (1994) 0.82
Involvement of calcium-independent phospholipase A2 in uterine stromal cell phospholipid remodelling. Eur J Biochem (2000) 0.82
Arachidonic acid up-regulates and prostaglandin E2 down-regulates the expression of pancreatic-type phospholipase A2 and prostaglandin-endoperoxide synthase 2 in uterine stromal cells. Eur J Biochem (1996) 0.81
Inhibition of thrombin-induced platelet arachidonic acid release by 15-hydroperoxy-arachidonic acid. Biochem Biophys Res Commun (1981) 0.81
Polyunsaturated fatty acids: drug or food? World Rev Nutr Diet (1984) 0.81
Characterization of A-2 receptors in postmortem human pineal gland. J Neurochem (1990) 0.81
Different metabolic behavior of long-chain n-3 polyunsaturated fatty acids in human platelets. Biochim Biophys Acta (1988) 0.81
Inhibition by lipoxygenase products of TXA2-like responses of platelets and vascular smooth muscle. 14-Hydroxy from 22:6n-3 is more potent than 12-HETE. Biochem Pharmacol (1988) 0.81
Constitutional thrombocytopathy with subnormal response to thromboxane A2. Br J Haematol (1981) 0.81
Impaired G-proteins and cyclic nucleotide phosphodiesterase activity in T-lymphocytes from patients with sarcoidosis. Eur J Clin Invest (1993) 0.81
Prostaglandin E2-like activity of 20:3n-9 platelet lipoxygenase end-product. FEBS Lett (1985) 0.81
Synthesis of acetyl,docosahexaenoyl-glycerophosphocholine and its characterization using nuclear magnetic resonance. Lipids (1999) 0.80
Control of cell proliferation via transduction of sPLA(2)-I activity and possible PPAR activation at the nuclear level. FEBS Lett (2001) 0.80
Relationships between phosphatidic acid and cyclic nucleotide phosphodiesterases in activated human blood mononuclear cells. J Leukoc Biol (1999) 0.80
Distribution of tritium labeled 12(S) hydroxy-eicosatetraenoic acid (12-HETE) in the rat. Prostaglandins (1991) 0.80
Esterification of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid into the phospholipids of human peripheral blood mononuclear cells: inhibition of the proliferative response. J Cell Physiol (1995) 0.80
Phospholipid analysis and fatty acid content in platelets by the combination of high-performance liquid chromatography and glass capillary gas--liquid chromatography. J Chromatogr (1983) 0.80
Impairment of platelet thromboxane A2 generation and of the platelet release reaction in two patients with congenital deficiency of platelet cyclo-oxygenase. Br J Haematol (1978) 0.80
Decreased arachidonic acid metabolism in human platelets by autologous neutrophils: possible role of cell adhesion. Biochem J (1994) 0.80
In vitro and in vivo alterations of enzymatic glycosylation in diabetes. Life Sci (1999) 0.80
Leukotriene B4 production by blood neutrophils in allergic rhinitis--effects of cetirizine. Clin Exp Allergy (1995) 0.80
Leukotriene B4 levels from stimulated neutrophils from healthy and allergic subjects: effect of platelets and exogenous arachidonic acid. Eur J Clin Invest (1991) 0.80
Enrichment of platelet phospholipids with eicosapentaenoic acid and docosahexaenoic acid inhibits thromboxane A2/prostaglandin H2 receptor binding and function. J Biol Chem (1990) 0.80
Effects of low doses of thrombin on human platelet phospholipids. Thromb Res (1980) 0.79
Astrocytes are mainly responsible for the polyunsaturated fatty acid enrichment in blood-brain barrier endothelial cells in vitro. J Lipid Res (1998) 0.79
In vitro incorporation and metabolism of some icosaenoic acids in platelets. Effect on arachidonic acid oxygenation. Biochim Biophys Acta (1985) 0.79
Nicergoline, an anti-aggregating agent which inhibits release of arachidonic acid from human platelet phospholipids. Prostaglandins (1980) 0.79
Identification of minor proteins of human colostrum and mature milk by two-dimensional electrophoresis. Electrophoresis (1998) 0.79